A Single-Center Phase 3 Study of RELAXaHEAD: A Behavioral Approach to Remote Migraine Management in Primary Care

Go Back to All Clinical Trials

A Single-Center Phase 3 Study of RELAXaHEAD: A Behavioral Approach to Remote Migraine Management in Primary Care

Brief description of study

Migraine is the second most disabling condition worldwide. We know that it can be hard for patients to access migraine care. Thus, we are conducting a study for patients of NYU Langone Health who have migraine. Specifically, NYU patients who have visited primary care, have a diagnosis of migraine, and are ages 16+ with 4+ headache days per month will be asked to take part in a smartphone-based migraine self- management program to determine if it will improve migraine-related disability, quality of life and headache days.

In this study you will be asked to keep track of your headaches using a headache diary app called RELAXaHEAD. This app will allow you to keep track of your headache days, pain level, sleep, medications, cycle, and notes. Participation time for this intervention can be up to 15 minutes a day for 6 weeks. We will also continue to track use for up to 6 months to see if you think the management program is helpful beyond the initial 6 weeks.

Clinical Study Identifier: s22-01208

ClinicalTrials.gov Identifier: NCT06077838

Principal Investigator: Mia T. Minen.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies